Surveillance and Modification of Immunosuppression Minimizes BK Virus Nephropathy

被引:19
作者
Bennett, William M. [1 ]
Meyer, Leslie [1 ]
Ridenour, Jennifer [1 ]
Batiuk, Thomas D. [1 ]
机构
[1] Legacy Good Samaritan Med Ctr, Transplant Serv, Portland, OR 97210 USA
关键词
BK virus; BK nephropathy; Renal transplant; Immunosuppression; KIDNEY-TRANSPLANTATION; REDUCTION; IMPACT;
D O I
10.1159/000313888
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Infection of a transplanted kidney with the polyomavirus, BK, is associated with poor allograft survival. Methods: In an attempt to prevent this transplant complication, we studied 144 consecutive transplant recipients for the presence of BK infection with plasma and urine PCR testing at 1, 2, 3, 6 and 12 months. Viruria alone was followed by serial studies. If plasma PCR became positive at >2.6 log copies, mycophenolate was reduced until there was no detectable plasma viral load. Results: Urine PCR was positive in 34 (24%), while plasma PCR turned positive in 22 cases (15%). No patients developed viremia with <6.8 log copies in the urine. Viremia resolved within 3 months or less in 20 of 22 patients after reduction of immunosuppression. Surveillance biopsies at 2 and 6 months revealed no BK nephropathy. Eight patients had acute rejection during reduced immunosuppression; however, all of these reversed with pulse steroids. Patient and graft survival at 1 year was 99 and 98%, respectively. Use of the cell-mediated immunity assay (ImmuKnow (R), Columbia, Md., USA) was not useful in identifying infected patients. Conclusion: Active surveillance for BK virus by urine/plasma PCR with prompt reduction in immunosuppression can prevent BK nephropathy. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:10 / 12
页数:3
相关论文
共 12 条
[1]   Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples [J].
Babel, Nina ;
Fendt, Juliane ;
Karaivanov, Stoyan ;
Bold, Gantuja ;
Arnold, Steffen ;
Sefrin, Anett ;
Lieske, Evelyn ;
Hoffzimmer, Martin ;
Dziubianau, Mikalai ;
Bethke, Nicole ;
Meisel, Christian ;
Gruetz, Gerald ;
Reinke, Petra .
TRANSPLANTATION, 2009, 88 (01) :89-95
[2]  
Boldorini R, 2009, ARCH PATHOL LAB MED, V133, P766, DOI 10.1043/1543-2165-133.5.766
[3]   Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction [J].
Brennan, DC ;
Agha, I ;
Bohl, DL ;
Schnitzler, MA ;
Hardinger, HL ;
Lockwood, M ;
Torrence, S ;
Schuessler, R ;
Roby, T ;
Gaudreault-Keener, M ;
Storch, GA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) :582-594
[4]   Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load [J].
Drachenberg, CB ;
Papadimitriou, JC ;
Hirsch, HH ;
Wali, R ;
Crowder, C ;
Nogueira, J ;
Cangro, CB ;
Mendley, S ;
Mian, A ;
Ramos, E .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2082-2092
[5]   Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation [J].
Faguer, Stanislas ;
Hirsch, Hans H. ;
Kamar, Nassim ;
Guilbeau-Frugier, Celine ;
Ribes, David ;
Guitard, Joelle ;
Esposito, Laure ;
Cointault, Olivier ;
Modesto, Anne ;
Lavit, Michel ;
Mengelle, Catherine ;
Rostaing, Lionel .
TRANSPLANT INTERNATIONAL, 2007, 20 (11) :962-969
[6]   BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results [J].
Hardinger, K. L. ;
Koch, M. J. ;
Bohl, D. J. ;
Storch, G. A. ;
Brennan, D. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (02) :407-415
[7]   BK virus nephritis after renal transplantation [J].
Hariharan, S .
KIDNEY INTERNATIONAL, 2006, 69 (04) :655-662
[8]   Maintenance Immunosuppressive Agents as Risk Factors for BK Virus Nephropathy: A Case-Control Study [J].
Manitpisitkul, Wana ;
Drachenberg, Cinthia ;
Ramos, Emilio ;
Munivenkatappa, Raghava ;
Philosophe, Benjamin ;
Klassen, David ;
Haririan, Abdolreza .
TRANSPLANTATION, 2009, 88 (01) :83-88
[9]  
Nickeleit V, 2006, ADV EXP MED BIOL, V577, P190
[10]   Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. [J].
Nickeleit, V ;
Klimkait, T ;
Binet, IF ;
Dalquen, P ;
Del Zenero, V ;
Thiel, G ;
Mihatsch, MJ ;
Hirsch, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1309-1315